25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Vitrolife AB
Buy, Hold or Sell?

Let's analyze Vitrolife together

I guess you are interested in Vitrolife AB. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Vitrolife AB. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Vitrolife AB

I send you an email if I find something interesting about Vitrolife AB.

1. Quick Overview

1.1. Quick analysis of Vitrolife (30 sec.)










1.2. What can you expect buying and holding a share of Vitrolife? (30 sec.)

How much money do you get?

How much money do you get?
kr0.09
When do you have the money?
1 year
How often do you get paid?
42.5%

What is your share worth?

Current worth
kr96.92
Expected worth in 1 year
kr65.10
How sure are you?
82.5%

+ What do you gain per year?

Total Gains per Share
kr-30.83
Return On Investment
-13.8%

For what price can you sell your share?

Current Price per Share
kr222.90
Expected price per share
kr201.00 - kr242.80
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Vitrolife (5 min.)




Live pricePrice per Share (EOD)
kr222.90
Intrinsic Value Per Share
kr34.13 - kr51.70
Total Value Per Share
kr131.05 - kr148.62

2.2. Growth of Vitrolife (5 min.)




Is Vitrolife growing?

Current yearPrevious yearGrowGrow %
How rich?$1.1b$1.5b-$379.3m-31.9%

How much money is Vitrolife making?

Current yearPrevious yearGrowGrow %
Making money-$86.5m$9.1m-$95.7m-110.6%
Net Profit Margin-105.0%11.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Vitrolife (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Vitrolife?

Welcome investor! Vitrolife's management wants to use your money to grow the business. In return you get a share of Vitrolife.

First you should know what it really means to hold a share of Vitrolife. And how you can make/lose money.

Speculation

The Price per Share of Vitrolife is kr222.90. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Vitrolife.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Vitrolife, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr96.92. Based on the TTM, the Book Value Change Per Share is kr-7.96 per quarter. Based on the YOY, the Book Value Change Per Share is kr1.90 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.25 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Vitrolife.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps0.080.0%-0.64-0.3%0.070.0%-0.070.0%-0.010.0%
Usd Book Value Change Per Share0.020.0%-0.72-0.3%0.170.1%0.370.2%0.210.1%
Usd Dividend Per Share0.000.0%0.020.0%0.040.0%0.020.0%0.020.0%
Usd Total Gains Per Share0.020.0%-0.70-0.3%0.210.1%0.390.2%0.230.1%
Usd Price Per Share23.30-18.79-17.43-22.39-25.27-
Price to Earnings Ratio74.82-43.32-67.22-107.71-125.82-
Price-to-Total Gains Ratio1,318.66--2,727.23-26.68--466.98-63.38-
Price to Book Ratio2.64-2.14-1.51-6.08-18.74-
Price-to-Total Gains Ratio1,318.66--2,727.23-26.68--466.98-63.38-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share20.2839
Number of shares49
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.02
Usd Book Value Change Per Share-0.720.37
Usd Total Gains Per Share-0.700.39
Gains per Quarter (49 shares)-34.3619.20
Gains per Year (49 shares)-137.4576.82
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
14-142-14757267
29-284-2849144144
313-426-42114217221
418-568-55818289298
522-709-69523361375
627-851-83227433452
731-993-96932506529
836-1135-110637578606
940-1277-124341650683
1044-1419-138046722760

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%11.01.00.091.7%19.01.00.095.0%39.01.00.097.5%59.02.00.096.7%
Book Value Change Per Share2.02.00.050.0%8.04.00.066.7%14.06.00.070.0%32.08.00.080.0%47.013.01.077.0%
Dividend per Share1.00.03.025.0%8.00.04.066.7%10.00.010.050.0%17.00.023.042.5%18.00.043.029.5%
Total Gains per Share2.02.00.050.0%8.04.00.066.7%15.05.00.075.0%33.07.00.082.5%48.012.01.078.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Vitrolife AB compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.194-7.956+4197%1.900-90%4.050-95%2.326-92%
Book Value Per Share--96.92096.338+1%127.156-24%78.395+24%44.425+118%
Current Ratio--2.9143.255-10%2.789+4%5.076-43%4.594-37%
Debt To Asset Ratio--0.2220.221+0%0.182+22%0.172+29%0.175+27%
Debt To Equity Ratio--0.2850.284+0%0.222+28%0.211+35%0.215+32%
Dividend Per Share---0.249-100%0.427-100%0.257-100%0.206-100%
Enterprise Value--31895050149.47525155553611.831+27%22772627680.225+40%28506881281.994+12%32693932153.767-2%
Eps--0.856-7.026+921%0.742+15%-0.809+194%-0.113+113%
Ev To Ebitda Ratio--46.09120.714+123%20.495+125%44.686+3%77.779-41%
Ev To Sales Ratio--9.1977.122+29%6.570+40%13.945-34%25.778-64%
Free Cash Flow Per Share--1.1801.196-1%1.265-7%1.028+15%0.827+43%
Free Cash Flow To Equity Per Share--0.6570.696-6%0.6570%3.119-79%1.785-63%
Gross Profit Margin---0.638-0.109-83%-0.708+11%-0.315-51%-0.015-98%
Intrinsic Value_10Y_max--51.698--------
Intrinsic Value_10Y_min--34.134--------
Intrinsic Value_1Y_max--4.315--------
Intrinsic Value_1Y_min--3.350--------
Intrinsic Value_3Y_max--13.626--------
Intrinsic Value_3Y_min--10.186--------
Intrinsic Value_5Y_max--23.730--------
Intrinsic Value_5Y_min--17.102--------
Market Cap--34715050149.47527961053611.831+24%25926377680.225+34%29963841781.994+16%31763359721.079+9%
Net Profit Margin--0.134-1.050+885%0.116+15%-0.070+152%0.090+49%
Operating Margin--0.201-0.980+588%0.201+0%0.002+8214%0.149+35%
Operating Ratio--0.7990.785+2%0.805-1%0.762+5%0.726+10%
Pb Ratio2.300-15%2.6422.142+23%1.507+75%6.083-57%18.741-86%
Pe Ratio65.124-15%74.81743.316+73%67.224+11%107.707-31%125.818-41%
Price Per Share222.900-15%256.075206.431+24%191.488+34%246.086+4%277.639-8%
Price To Free Cash Flow Ratio47.215-15%54.24244.260+23%38.564+41%46.807+16%138.672-61%
Price To Total Gains Ratio1147.824-15%1318.658-2727.232+307%26.681+4842%-466.984+135%63.379+1981%
Quick Ratio--2.2562.471-9%2.000+13%4.178-46%3.602-37%
Return On Assets--0.007-0.058+947%0.005+44%0.004+86%0.025-72%
Return On Equity--0.009-0.075+950%0.006+52%0.003+206%0.029-70%
Total Gains Per Share--0.194-7.706+4068%2.327-92%4.307-95%2.532-92%
Usd Book Value--1195649000.0001187368000.000+1%1566678750.000-24%928256206.150+29%515615946.300+132%
Usd Book Value Change Per Share--0.018-0.724+4197%0.173-90%0.369-95%0.212-92%
Usd Book Value Per Share--8.8208.767+1%11.571-24%7.134+24%4.043+118%
Usd Dividend Per Share---0.023-100%0.039-100%0.023-100%0.019-100%
Usd Enterprise Value--2902449563.6022289155378.677+27%2072309118.900+40%2594126196.661+12%2975147825.993-2%
Usd Eps--0.078-0.639+921%0.068+15%-0.074+194%-0.010+113%
Usd Free Cash Flow--14560000.00014742000.000-1%15583750.000-7%11756594.850+24%8967481.250+62%
Usd Free Cash Flow Per Share--0.1070.109-1%0.115-7%0.094+15%0.075+43%
Usd Free Cash Flow To Equity Per Share--0.0600.063-6%0.0600%0.284-79%0.162-63%
Usd Market Cap--3159069563.6022544455878.677+24%2359300368.900+34%2726709602.161+16%2890465734.618+9%
Usd Price Per Share20.284-15%23.30318.785+24%17.425+34%22.394+4%25.265-8%
Usd Profit--10556000.000-86563750.000+920%9145500.000+15%-10735297.300+202%-2497429.025+124%
Usd Revenue--78897000.00080830750.000-2%78760500.000+0%57920867.550+36%40298003.200+96%
Usd Total Gains Per Share--0.018-0.701+4068%0.212-92%0.392-95%0.230-92%
 EOD+4 -2MRQTTM+22 -18YOY+20 -205Y+23 -1710Y+19 -21

3.3 Fundamental Score

Let's check the fundamental score of Vitrolife AB based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1565.124
Price to Book Ratio (EOD)Between0-12.300
Net Profit Margin (MRQ)Greater than00.134
Operating Margin (MRQ)Greater than00.201
Quick Ratio (MRQ)Greater than12.256
Current Ratio (MRQ)Greater than12.914
Debt to Asset Ratio (MRQ)Less than10.222
Debt to Equity Ratio (MRQ)Less than10.285
Return on Equity (MRQ)Greater than0.150.009
Return on Assets (MRQ)Greater than0.050.007
Total6/10 (60.0%)

3.4 Technical Score

Let's check the technical score of Vitrolife AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.704
Ma 20Greater thanMa 50211.905
Ma 50Greater thanMa 100215.733
Ma 100Greater thanMa 200229.025
OpenGreater thanClose222.900
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Vitrolife AB

Vitrolife AB (publ) provides assisted reproduction products. It also offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. In addition, the company offers EmbryoScope and time-lapse systems; time-lapse dishes; and evaluation tools for time-lapse systems. The company operates in Europe, the Middle East, India and Africa; Asia; Japan and Pacific; Americas; and Asia. Vitrolife AB (publ) was incorporated in 1989 and is based in Gothenburg, Sweden.

Fundamental data was last updated by Penke on 2025-01-23 08:21:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is fair priced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Vitrolife earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Vitrolife to the  industry mean.
  • A Net Profit Margin of 13.4% means that kr0.13 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Vitrolife AB:

  • The MRQ is 13.4%. The company is making a huge profit. +2
  • The TTM is -105.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ13.4%TTM-105.0%+118.4%
TTM-105.0%YOY11.6%-116.6%
TTM-105.0%5Y-7.0%-98.0%
5Y-7.0%10Y9.0%-16.0%
4.3.1.2. Return on Assets

Shows how efficient Vitrolife is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Vitrolife to the  industry mean.
  • 0.7% Return on Assets means that Vitrolife generated kr0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Vitrolife AB:

  • The MRQ is 0.7%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is -5.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.7%TTM-5.8%+6.5%
TTM-5.8%YOY0.5%-6.3%
TTM-5.8%5Y0.4%-6.2%
5Y0.4%10Y2.5%-2.1%
4.3.1.3. Return on Equity

Shows how efficient Vitrolife is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Vitrolife to the  industry mean.
  • 0.9% Return on Equity means Vitrolife generated kr0.01 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Vitrolife AB:

  • The MRQ is 0.9%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is -7.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.9%TTM-7.5%+8.4%
TTM-7.5%YOY0.6%-8.1%
TTM-7.5%5Y0.3%-7.8%
5Y0.3%10Y2.9%-2.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Vitrolife AB.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Vitrolife is operating .

  • Measures how much profit Vitrolife makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Vitrolife to the  industry mean.
  • An Operating Margin of 20.1% means the company generated kr0.20  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Vitrolife AB:

  • The MRQ is 20.1%. The company is operating efficient. +1
  • The TTM is -98.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ20.1%TTM-98.0%+118.1%
TTM-98.0%YOY20.1%-118.1%
TTM-98.0%5Y0.2%-98.3%
5Y0.2%10Y14.9%-14.6%
4.3.2.2. Operating Ratio

Measures how efficient Vitrolife is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 0.80 means that the operating costs are kr0.80 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Vitrolife AB:

  • The MRQ is 0.799. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.785. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.799TTM0.785+0.014
TTM0.785YOY0.805-0.020
TTM0.7855Y0.762+0.023
5Y0.76210Y0.726+0.036
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Vitrolife AB.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Vitrolife is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 2.91 means the company has kr2.91 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Vitrolife AB:

  • The MRQ is 2.914. The company is able to pay all its short-term debts. +1
  • The TTM is 3.255. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ2.914TTM3.255-0.341
TTM3.255YOY2.789+0.466
TTM3.2555Y5.076-1.821
5Y5.07610Y4.594+0.482
4.4.3.2. Quick Ratio

Measures if Vitrolife is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Vitrolife to the  industry mean.
  • A Quick Ratio of 2.26 means the company can pay off kr2.26 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Vitrolife AB:

  • The MRQ is 2.256. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.471. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.256TTM2.471-0.216
TTM2.471YOY2.000+0.471
TTM2.4715Y4.178-1.707
5Y4.17810Y3.602+0.576
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Vitrolife AB.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Vitrolife assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Vitrolife to industry mean.
  • A Debt to Asset Ratio of 0.22 means that Vitrolife assets are financed with 22.2% credit (debt) and the remaining percentage (100% - 22.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Vitrolife AB:

  • The MRQ is 0.222. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.221. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.222TTM0.221+0.001
TTM0.221YOY0.182+0.039
TTM0.2215Y0.172+0.049
5Y0.17210Y0.175-0.002
4.5.4.2. Debt to Equity Ratio

Measures if Vitrolife is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Vitrolife to the  industry mean.
  • A Debt to Equity ratio of 28.5% means that company has kr0.29 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Vitrolife AB:

  • The MRQ is 0.285. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.284. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.285TTM0.284+0.001
TTM0.284YOY0.222+0.062
TTM0.2845Y0.211+0.072
5Y0.21110Y0.215-0.004
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Vitrolife generates.

  • Above 15 is considered overpriced but always compare Vitrolife to the  industry mean.
  • A PE ratio of 74.82 means the investor is paying kr74.82 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Vitrolife AB:

  • The EOD is 65.124. Based on the earnings, the company is expensive. -2
  • The MRQ is 74.817. Based on the earnings, the company is expensive. -2
  • The TTM is 43.316. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD65.124MRQ74.817-9.693
MRQ74.817TTM43.316+31.500
TTM43.316YOY67.224-23.907
TTM43.3165Y107.707-64.391
5Y107.70710Y125.818-18.111
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Vitrolife AB:

  • The EOD is 47.215. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 54.242. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 44.260. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD47.215MRQ54.242-7.027
MRQ54.242TTM44.260+9.982
TTM44.260YOY38.564+5.696
TTM44.2605Y46.807-2.547
5Y46.80710Y138.672-91.865
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Vitrolife is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 2.64 means the investor is paying kr2.64 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Vitrolife AB:

  • The EOD is 2.300. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.642. Based on the equity, the company is underpriced. +1
  • The TTM is 2.142. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.300MRQ2.642-0.342
MRQ2.642TTM2.142+0.500
TTM2.142YOY1.507+0.635
TTM2.1425Y6.083-3.941
5Y6.08310Y18.741-12.658
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-09-302023-12-312024-03-312024-06-302024-09-30
Depreciation and Amortization  109,0000109,000-4,000105,0004,000109,000-110,000-1,000



6.2. Latest Balance Sheet

Balance Sheet of 2024-09-30. All numbers in thousands.

Summary
Total Assets16,884,000
Total Liabilities3,745,000
Total Stockholder Equity13,137,000
 As reported
Total Liabilities 3,745,000
Total Stockholder Equity+ 13,137,000
Total Assets = 16,884,000

Assets

Total Assets16,884,000
Total Current Assets2,110,000
Long-term Assets14,774,000
Total Current Assets
Cash And Cash Equivalents 925,000
Net Receivables 708,000
Inventory 403,000
Total Current Assets  (as reported)2,110,000
Total Current Assets  (calculated)2,036,000
+/- 74,000
Long-term Assets
Property Plant Equipment 391,000
Goodwill 9,857,000
Intangible Assets 4,318,000
Long-term Assets  (as reported)14,774,000
Long-term Assets  (calculated)14,566,000
+/- 208,000

Liabilities & Shareholders' Equity

Total Current Liabilities724,000
Long-term Liabilities3,021,000
Total Stockholder Equity13,137,000
Total Current Liabilities
Short-term Debt 152,000
Accounts payable 190,000
Other Current Liabilities 280,000
Total Current Liabilities  (as reported)724,000
Total Current Liabilities  (calculated)622,000
+/- 102,000
Long-term Liabilities
Long-term Liabilities  (as reported)3,021,000
Long-term Liabilities  (calculated)0
+/- 3,021,000
Total Stockholder Equity
Common Stock28,000
Retained Earnings -1,749,000
Accumulated Other Comprehensive Income 1,315,000
Other Stockholders Equity 13,543,000
Total Stockholder Equity (as reported)13,137,000
Total Stockholder Equity (calculated)13,137,000
+/-0
Other
Cash and Short Term Investments 925,000
Common Stock Shares Outstanding 135,566
Current Deferred Revenue102,000
Liabilities and Stockholders Equity 16,884,000
Net Debt 1,125,000
Net Working Capital 1,386,000
Short Long Term Debt Total 2,050,000



6.3. Balance Sheets Structured

All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-30
> Total Assets 
0
0
359,315
0
389,393
388,251
429,388
436,471
442,136
463,004
466,780
473,881
501,471
495,293
462,198
465,841
479,565
467,236
487,808
497,442
505,265
554,346
972,482
960,446
957,279
993,135
1,059,243
1,107,151
1,128,830
1,189,371
1,250,491
1,286,096
1,302,928
1,317,216
1,422,424
1,550,134
1,566,360
1,619,292
1,697,467
1,880,172
1,952,673
2,092,341
2,138,687
2,247,569
2,203,185
2,255,316
2,305,089
2,497,494
2,513,722
6,140,833
19,428,796
19,535,000
19,907,000
20,206,000
20,551,000
20,762,000
21,648,000
21,180,000
16,391,000
16,873,000
16,852,000
16,884,000
16,884,00016,852,00016,873,00016,391,00021,180,00021,648,00020,762,00020,551,00020,206,00019,907,00019,535,00019,428,7966,140,8332,513,7222,497,4942,305,0892,255,3162,203,1852,247,5692,138,6872,092,3411,952,6731,880,1721,697,4671,619,2921,566,3601,550,1341,422,4241,317,2161,302,9281,286,0961,250,4911,189,3711,128,8301,107,1511,059,243993,135957,279960,446972,482554,346505,265497,442487,808467,236479,565465,841462,198495,293501,471473,881466,780463,004442,136436,471429,388388,251389,3930359,31500
   > Total Current Assets 
0
0
103,818
0
115,751
118,378
131,563
137,267
133,610
144,556
153,436
164,696
242,131
249,369
142,816
155,863
161,969
161,664
187,325
203,255
213,122
260,255
308,782
301,490
314,634
354,566
414,454
466,823
340,605
397,477
476,519
532,647
562,887
604,247
709,905
757,817
777,613
849,720
850,576
956,480
918,350
1,069,634
1,150,224
1,237,464
1,239,973
1,310,340
1,414,442
1,593,101
1,623,547
5,252,743
1,406,601
1,409,000
1,328,000
1,408,000
1,572,000
1,653,000
1,816,000
1,825,000
1,914,000
2,048,000
1,998,000
2,110,000
2,110,0001,998,0002,048,0001,914,0001,825,0001,816,0001,653,0001,572,0001,408,0001,328,0001,409,0001,406,6015,252,7431,623,5471,593,1011,414,4421,310,3401,239,9731,237,4641,150,2241,069,634918,350956,480850,576849,720777,613757,817709,905604,247562,887532,647476,519397,477340,605466,823414,454354,566314,634301,490308,782260,255213,122203,255187,325161,664161,969155,863142,816249,369242,131164,696153,436144,556133,610137,267131,563118,378115,7510103,81800
       Cash And Cash Equivalents 
0
0
15,987
0
11,344
9,608
18,617
17,811
10,408
15,516
20,873
26,764
19,115
15,018
11,680
19,309
18,824
30,997
53,769
65,514
70,805
119,274
107,598
90,458
75,648
115,902
199,572
202,333
75,971
118,651
189,245
218,078
235,739
285,055
395,963
399,289
421,397
496,225
490,810
522,078
446,548
599,010
689,538
715,478
753,796
834,256
973,566
1,117,594
1,155,482
4,763,324
630,094
583,000
444,000
461,000
578,000
618,000
687,000
778,000
861,000
947,000
853,000
925,000
925,000853,000947,000861,000778,000687,000618,000578,000461,000444,000583,000630,0944,763,3241,155,4821,117,594973,566834,256753,796715,478689,538599,010446,548522,078490,810496,225421,397399,289395,963285,055235,739218,078189,245118,65175,971202,333199,572115,90275,64890,458107,598119,27470,80565,51453,76930,99718,82419,30911,68015,01819,11526,76420,87315,51610,40817,81118,6179,60811,344015,98700
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
289
0
0
0
120
0
0
0
17
0
0
0
842
0
0
0
0
0
0
0
0
0
0
0
-1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000-1000000000008420001700012000028900000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
52,436
56,584
68,046
54,193
61,456
63,222
69,595
65,526
84,620
92,259
109,846
104,542
99,783
112,201
121,444
126,906
133,514
160,841
178,186
173,145
153,614
194,970
184,818
186,025
189,231
239,900
259,966
250,537
240,179
274,530
218,978
236,751
216,494
248,319
227,707
239,138
431,156
455,000
459,000
492,000
542,000
573,000
612,000
535,000
503,000
645,000
697,000
708,000
708,000697,000645,000503,000535,000612,000573,000542,000492,000459,000455,000431,156239,138227,707248,319216,494236,751218,978274,530240,179250,537259,966239,900189,231186,025184,818194,970153,614173,145178,186160,841133,514126,906121,444112,20199,783104,542109,84692,25984,62065,52669,59563,22261,45654,19368,04656,58452,43600000000000000
       Other Current Assets 
0
0
45,984
0
56,573
53,941
56,336
67,021
67,383
68,637
66,854
69,438
159,855
171,694
68,727
17,520
10,804
13,292
12,064
12,971
11,971
12,332
24,871
20,460
23,472
22,551
11,973
45,969
19,235
17,086
15,433
15,177
17,234
14,302
15,150
23,334
23,392
19,779
17,578
25,385
28,916
21,813
18,545
29,258
46,157
46,799
20,355
22,981
28,805
24,541
32,457
76,000
67,000
113,000
135,000
122,000
137,000
115,000
137,000
133,000
167,000
782,000
782,000167,000133,000137,000115,000137,000122,000135,000113,00067,00076,00032,45724,54128,80522,98120,35546,79946,15729,25818,54521,81328,91625,38517,57819,77923,39223,33415,15014,30217,23415,17715,43317,08619,23545,96911,97322,55123,47220,46024,87112,33211,97112,97112,06413,29210,80417,52068,727171,694159,85569,43866,85468,63767,38367,02156,33653,94156,573045,98400
   > Long-term Assets 
0
0
255,497
0
273,642
269,873
297,825
299,204
308,526
318,448
313,344
309,185
259,340
245,924
319,382
309,978
317,596
305,572
300,483
294,187
292,143
294,091
663,700
658,956
642,645
638,569
644,789
640,328
788,225
791,894
773,972
753,449
740,041
712,969
712,519
792,317
788,747
769,572
846,891
923,692
1,034,323
1,022,707
988,463
1,010,105
963,212
944,976
890,648
904,393
890,177
888,090
18,022,195
18,126,000
18,579,000
18,798,000
18,978,000
19,109,000
19,832,000
19,355,000
14,477,000
14,825,000
14,854,000
14,774,000
14,774,00014,854,00014,825,00014,477,00019,355,00019,832,00019,109,00018,978,00018,798,00018,579,00018,126,00018,022,195888,090890,177904,393890,648944,976963,2121,010,105988,4631,022,7071,034,323923,692846,891769,572788,747792,317712,519712,969740,041753,449773,972791,894788,225640,328644,789638,569642,645658,956663,700294,091292,143294,187300,483305,572317,596309,978319,382245,924259,340309,185313,344318,448308,526299,204297,825269,873273,6420255,49700
       Property Plant Equipment 
0
0
93,038
0
94,142
86,598
91,316
95,209
95,304
97,519
95,444
92,520
101,019
95,957
94,445
93,873
93,005
87,172
85,956
83,878
84,214
85,366
92,322
95,776
91,697
90,271
89,641
87,681
90,533
90,536
93,655
91,517
89,672
84,895
84,432
86,427
91,246
90,440
94,126
174,598
176,168
180,580
173,359
175,747
164,025
154,079
142,113
146,759
160,441
159,451
332,974
347,000
359,000
342,000
318,000
307,000
349,000
353,000
349,000
368,000
379,000
391,000
391,000379,000368,000349,000353,000349,000307,000318,000342,000359,000347,000332,974159,451160,441146,759142,113154,079164,025175,747173,359180,580176,168174,59894,12690,44091,24686,42784,43284,89589,67291,51793,65590,53690,53387,68189,64190,27191,69795,77692,32285,36684,21483,87885,95687,17293,00593,87394,44595,957101,01992,52095,44497,51995,30495,20991,31686,59894,142093,03800
       Goodwill 
0
0
97,301
0
97,301
97,301
120,289
118,221
118,355
0
120,771
0
0
114,995
182,114
175,586
182,670
180,105
183,275
180,969
183,789
185,400
364,545
364,835
358,394
364,252
350,474
351,793
394,052
402,128
403,216
402,393
404,806
399,718
408,937
422,562
424,994
421,583
421,610
427,790
430,915
435,619
425,841
442,311
422,241
421,413
403,239
411,717
409,736
411,441
12,994,620
13,111,000
13,461,000
13,696,000
13,874,000
14,025,000
14,552,000
14,244,000
9,591,000
9,867,000
9,898,000
9,857,000
9,857,0009,898,0009,867,0009,591,00014,244,00014,552,00014,025,00013,874,00013,696,00013,461,00013,111,00012,994,620411,441409,736411,717403,239421,413422,241442,311425,841435,619430,915427,790421,610421,583424,994422,562408,937399,718404,806402,393403,216402,128394,052351,793350,474364,252358,394364,835364,545185,400183,789180,969183,275180,105182,670175,586182,114114,99500120,7710118,355118,221120,28997,30197,301097,30100
       Intangible Assets 
0
0
34,506
0
48,163
54,417
65,323
68,358
76,681
0
83,666
0
0
21,316
33,892
32,376
40,760
37,058
22,982
19,176
18,368
17,136
196,846
187,339
181,957
175,556
165,044
161,926
266,288
261,432
245,871
231,768
221,415
204,929
198,801
264,339
254,046
238,500
306,387
293,777
382,119
371,280
352,417
352,931
329,079
319,669
299,480
295,615
281,676
268,808
4,552,903
4,536,000
4,609,000
4,635,000
4,648,000
4,629,000
4,755,000
4,573,000
4,312,000
4,403,000
4,384,000
4,318,000
4,318,0004,384,0004,403,0004,312,0004,573,0004,755,0004,629,0004,648,0004,635,0004,609,0004,536,0004,552,903268,808281,676295,615299,480319,669329,079352,931352,417371,280382,119293,777306,387238,500254,046264,339198,801204,929221,415231,768245,871261,432266,288161,926165,044175,556181,957187,339196,84617,13618,36819,17622,98237,05840,76032,37633,89221,3160083,666076,68168,35865,32354,41748,163034,50600
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
25,847
4,918
0
0
12,059
4,616
0
0
111,070
0
0
0
102,053
29,557
29,246
29,676
89,281
18,854
14,986
14,327
62,953
6,283
4,850
662
43,071
1,409
14,347
2,814
40,697
4,092
4,594
5,001
-1
10,118
-2
48,390
200,000
132,000
150,000
125,000
1,000
148,000
176,000
185,000
0
0
0
0
0000185,000176,000148,0001,000125,000150,000132,000200,00048,390-210,118-15,0014,5944,09240,6972,81414,3471,40943,0716624,8506,28362,95314,32714,98618,85489,28129,67629,24629,557102,053000111,070004,61612,059004,91825,84700000000000000
> Total Liabilities 
0
0
47,246
0
57,129
60,475
103,055
110,932
119,260
122,762
122,877
123,823
144,491
523,516
183,216
179,948
186,867
162,468
165,208
155,332
162,006
170,096
269,911
218,618
220,079
192,178
214,271
222,555
233,056
233,124
230,107
209,265
213,468
176,507
193,775
218,738
221,269
208,358
201,255
282,941
349,328
364,709
341,059
320,958
315,638
294,616
288,075
333,539
362,780
364,747
4,087,926
3,993,000
3,917,000
3,804,000
3,811,000
3,747,000
3,969,000
3,749,000
3,668,000
3,640,000
3,755,000
3,745,000
3,745,0003,755,0003,640,0003,668,0003,749,0003,969,0003,747,0003,811,0003,804,0003,917,0003,993,0004,087,926364,747362,780333,539288,075294,616315,638320,958341,059364,709349,328282,941201,255208,358221,269218,738193,775176,507213,468209,265230,107233,124233,056222,555214,271192,178220,079218,618269,911170,096162,006155,332165,208162,468186,867179,948183,216523,516144,491123,823122,877122,762119,260110,932103,05560,47557,129047,24600
   > Total Current Liabilities 
0
0
40,053
0
51,302
55,451
71,284
76,232
88,083
91,182
61,332
71,060
90,539
474,286
80,168
92,663
111,730
95,280
99,724
100,565
106,353
118,278
159,831
135,093
143,723
126,426
131,396
139,800
124,881
128,385
159,318
141,295
147,575
116,316
134,895
130,401
132,617
120,702
152,275
163,862
191,770
223,092
202,352
180,523
181,878
169,054
177,014
220,844
240,548
245,494
954,326
918,000
748,000
670,000
621,000
596,000
651,000
596,000
557,000
556,000
669,000
724,000
724,000669,000556,000557,000596,000651,000596,000621,000670,000748,000918,000954,326245,494240,548220,844177,014169,054181,878180,523202,352223,092191,770163,862152,275120,702132,617130,401134,895116,316147,575141,295159,318128,385124,881139,800131,396126,426143,723135,093159,831118,278106,353100,56599,72495,280111,73092,66380,168474,28690,53971,06061,33291,18288,08376,23271,28455,45151,302040,05300
       Short-term Debt 
0
0
2,981
0
10,389
13,012
20,406
29,393
37,947
40,589
5,424
10,653
12,413
399,034
16,825
71,848
94,942
83,250
-39,421
16,820
17,166
16,385
-76,489
20,060
107,313
12,235
11,876
12,002
12,319
12,601
-36,796
34,207
31,518
79
-80,555
85
0
0
0
10,683
13,131
14,175
-155,057
15,409
15,147
14,440
-21,757
13,302
15,948
15,675
456,000
474,000
305,000
199,000
182,000
148,000
149,000
145,000
180,000
119,000
148,000
152,000
152,000148,000119,000180,000145,000149,000148,000182,000199,000305,000474,000456,00015,67515,94813,302-21,75714,44015,14715,409-155,05714,17513,13110,68300085-80,5557931,51834,207-36,79612,60112,31912,00211,87612,235107,31320,060-76,48916,38517,16616,820-39,42183,25094,94271,84816,825399,03412,41310,6535,42440,58937,94729,39320,40613,01210,38902,98100
       Accounts payable 
0
0
14,697
0
16,274
19,642
26,643
19,286
17,380
18,206
19,865
23,743
21,258
18,464
17,444
20,815
16,788
12,030
15,596
17,567
11,106
19,444
22,282
20,436
20,415
17,668
21,749
22,785
21,806
23,272
24,286
24,609
24,274
27,793
30,598
24,876
28,195
26,483
32,085
40,039
36,088
40,517
29,314
30,934
38,850
23,848
25,922
47,601
46,901
45,079
173,000
179,000
187,000
201,000
181,000
174,000
224,000
163,000
171,000
164,000
167,000
190,000
190,000167,000164,000171,000163,000224,000174,000181,000201,000187,000179,000173,00045,07946,90147,60125,92223,84838,85030,93429,31440,51736,08840,03932,08526,48328,19524,87630,59827,79324,27424,60924,28623,27221,80622,78521,74917,66820,41520,43622,28219,44411,10617,56715,59612,03016,78820,81517,44418,46421,25823,74319,86518,20617,38019,28626,64319,64216,274014,69700
       Other Current Liabilities 
0
0
2,744
0
24,639
22,797
24,235
27,553
32,756
31,487
32,649
36,664
48,999
46,408
36,044
55,022
77,723
67,724
-6,646
64,511
76,138
81,656
-28,800
75,533
88,070
46,415
-35,771
68,454
54,604
51,919
-14,485
72,205
70,137
69,254
-9,220
2,640
96,201
85,876
90,502
21,254
11,351
-9,607
-11,867
11,974
31,498
20,376
101,377
10,255
19,889
-2,468
298,837
38,000
215,000
216,000
185,000
240,000
11,000
-1,000
135,000
197,000
208,000
280,000
280,000208,000197,000135,000-1,00011,000240,000185,000216,000215,00038,000298,837-2,46819,88910,255101,37720,37631,49811,974-11,867-9,60711,35121,25490,50285,87696,2012,640-9,22069,25470,13772,205-14,48551,91954,60468,454-35,77146,41588,07075,533-28,80081,65676,13864,511-6,64667,72477,72355,02236,04446,40848,99936,66432,64931,48732,75627,55324,23522,79724,63902,74400
   > Long-term Liabilities 
0
0
7,193
0
5,827
5,024
31,771
34,700
31,177
31,580
61,545
52,763
53,952
49,230
103,048
87,285
75,137
67,188
65,484
54,767
55,653
51,818
110,080
83,525
76,356
65,752
82,875
82,755
108,175
104,739
70,789
67,970
65,893
60,191
58,880
88,337
88,652
87,656
48,980
119,079
157,558
141,617
138,707
140,435
133,760
125,562
111,061
112,695
122,232
119,253
3,133,600
3,075,000
3,169,000
3,134,000
3,190,000
3,151,000
3,318,000
3,153,000
3,111,000
3,084,000
3,086,000
3,021,000
3,021,0003,086,0003,084,0003,111,0003,153,0003,318,0003,151,0003,190,0003,134,0003,169,0003,075,0003,133,600119,253122,232112,695111,061125,562133,760140,435138,707141,617157,558119,07948,98087,65688,65288,33758,88060,19165,89367,97070,789104,739108,17582,75582,87565,75276,35683,525110,08051,81855,65354,76765,48467,18875,13787,285103,04849,23053,95252,76361,54531,58031,17734,70031,7715,0245,82707,19300
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
66,644
1,106,779
1,092,000
1,131,000
1,125,000
1,147,000
1,144,000
0
0
0
0
0
0
0000001,144,0001,147,0001,125,0001,131,0001,092,0001,106,77966,6440000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
58,436
0
0
0
0
0
0
0
0
0
0
0
0000000000058,43600000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
311,588
0
331,572
327,075
325,676
324,755
321,961
339,278
342,970
349,022
355,858
-29,362
277,791
284,610
291,205
303,198
320,956
340,299
341,694
382,631
700,914
739,970
735,133
798,764
843,151
882,486
893,818
954,117
1,018,055
1,074,054
1,087,045
1,138,129
1,225,857
1,327,995
1,341,974
1,407,781
1,492,914
1,593,568
1,600,108
1,724,250
1,794,023
1,922,499
1,883,653
1,956,346
2,012,570
2,158,713
2,146,647
5,771,466
15,322,175
15,529,000
15,977,000
16,386,000
16,736,000
17,013,000
17,677,000
17,430,000
12,722,000
13,231,000
13,096,000
13,137,000
13,137,00013,096,00013,231,00012,722,00017,430,00017,677,00017,013,00016,736,00016,386,00015,977,00015,529,00015,322,1755,771,4662,146,6472,158,7132,012,5701,956,3461,883,6531,922,4991,794,0231,724,2501,600,1081,593,5681,492,9141,407,7811,341,9741,327,9951,225,8571,138,1291,087,0451,074,0541,018,055954,117893,818882,486843,151798,764735,133739,970700,914382,631341,694340,299320,956303,198291,205284,610277,791-29,362355,858349,022342,970339,278321,961324,755325,676327,075331,5720311,58800
   Common Stock
0
0
19,944
0
0
0
19,944
0
0
0
19,954
0
355,007
19,954
20,228
20,228
20,228
20,228
20,228
20,228
20,228
20,228
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
22,144
24,112
27,631
27,000
28,000
28,000
28,000
28,000
28,000
28,000
28,000
28,000
28,000
28,000
28,00028,00028,00028,00028,00028,00028,00028,00028,00028,00027,00027,63124,11222,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14422,14420,22820,22820,22820,22820,22820,22820,22820,22819,954355,007019,95400019,94400019,94400
   Retained Earnings Total Equity00000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-35,609
-40,552
-38,149
-40,984
-35,699
-30,255
-16,638
-12,569
-23,195
-11,888
-24,681
-23,773
-8,293
7,535
11,959
8,754
6,894
-6,782
12,567
43,344
58,378
49,118
50,254
65,590
69,764
87,200
60,846
109,486
59,015
53,657
1,924
516,754
17,319
25,519
20,584
169,000
595,000
892,000
1,164,000
1,341,000
2,009,000
1,641,000
1,144,000
1,541,000
1,394,000
1,315,000
1,315,0001,394,0001,541,0001,144,0001,641,0002,009,0001,341,0001,164,000892,000595,000169,00020,58425,51917,319516,7541,92453,65759,015109,48660,84687,20069,76465,59050,25449,11858,37843,34412,567-6,7826,8948,75411,9597,535-8,293-23,773-24,681-11,888-23,195-12,569-16,638-30,255-35,699-40,984-38,149-40,552-35,6090000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
483,763
494,610
494,610
494,610
4,025,886
0
0
0
0
0
0
0
0
0
0
0
0
0000000000004,025,886494,610494,610494,610483,763000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
190,181
0
331,572
327,075
185,116
324,755
321,961
339,278
185,254
349,022
0
-50,167
183,348
178,291
220,287
220,287
220,287
220,287
220,287
220,287
494,610
494,610
494,610
494,610
494,610
494,610
494,610
494,610
494,610
494,610
494,610
494,610
494,610
494,610
494,610
494,610
494,610
494,610
494,610
494,610
494,610
494,610
494,610
483,763
494,610
494,610
494,609
4,025,886
13,543,973
13,545,000
13,543,000
13,544,000
13,544,000
13,544,000
13,544,000
13,544,000
13,544,000
13,543,000
13,542,000
13,543,000
13,543,00013,542,00013,543,00013,544,00013,544,00013,544,00013,544,00013,544,00013,544,00013,543,00013,545,00013,543,9734,025,886494,609494,610494,610483,763494,610494,610494,610494,610494,610494,610494,610494,610494,610494,610494,610494,610494,610494,610494,610494,610494,610494,610494,610494,610494,610494,610494,610220,287220,287220,287220,287220,287220,287178,291183,348-50,1670349,022185,254339,278321,961324,755185,116327,075331,5720190,18100



6.4. Balance Sheets

All numbers in thousands.




6.5. Cash Flows

Currency in SEK. All numbers in thousands.




6.6. Income Statements

All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. All numbers in thousands.

Gross Profit (+$)
totalRevenue3,512,000
Cost of Revenue-1,534,000
Gross Profit1,978,0001,978,000
 
Operating Income (+$)
Gross Profit1,978,000
Operating Expense-5,567,000
Operating Income-3,589,000-3,589,000
 
Operating Expense (+$)
Research Development228,000
Selling General Administrative433,000
Selling And Marketing Expenses684,000
Operating Expense5,567,0001,345,000
 
Net Interest Income (+$)
Interest Income0
Interest Expense-94,000
Other Finance Cost-94,000
Net Interest Income0
 
Pretax Income (+$)
Operating Income-3,589,000
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-3,712,000-3,466,000
EBIT - interestExpense = -3,704,000
-3,712,000
-3,757,000
Interest Expense94,000
Earnings Before Interest and Taxes (EBIT)-3,610,000-3,618,000
Earnings Before Interest and Taxes (EBITDA)-3,185,000
 
After tax Income (+$)
Income Before Tax-3,712,000
Tax Provision-0
Net Income From Continuing Ops0-3,712,000
Net Income-3,851,000
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses7,101,000
Total Other Income/Expenses Net-123,0000
 

Technical Analysis of Vitrolife
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Vitrolife. The general trend of Vitrolife is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Vitrolife's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Vitrolife AB.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 229.60 < 242.80 < 242.80.

The bearish price targets are: 221.60 > 221.00 > 201.00.

Tweet this
Vitrolife AB Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Vitrolife AB. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Vitrolife AB Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Vitrolife AB. The current macd is -0.31689647.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Vitrolife price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Vitrolife. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Vitrolife price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Vitrolife AB Daily Moving Average Convergence/Divergence (MACD) ChartVitrolife AB Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Vitrolife AB. The current adx is 27.44.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Vitrolife shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Vitrolife AB Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Vitrolife AB. The current sar is 205.77.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Vitrolife AB Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Vitrolife AB. The current rsi is 60.70. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Vitrolife AB Daily Relative Strength Index (RSI) ChartVitrolife AB Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Vitrolife AB. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Vitrolife price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Vitrolife AB Daily Stochastic Oscillator ChartVitrolife AB Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Vitrolife AB. The current cci is 138.37.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Vitrolife AB Daily Commodity Channel Index (CCI) ChartVitrolife AB Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Vitrolife AB. The current cmo is 35.40.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Vitrolife AB Daily Chande Momentum Oscillator (CMO) ChartVitrolife AB Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Vitrolife AB. The current willr is -47.6076555.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Vitrolife is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Vitrolife AB Daily Williams %R ChartVitrolife AB Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Vitrolife AB.

Vitrolife AB Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Vitrolife AB. The current atr is 15.89.

Vitrolife AB Daily Average True Range (ATR) ChartVitrolife AB Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Vitrolife AB. The current obv is 1,704,715.

Vitrolife AB Daily On-Balance Volume (OBV) ChartVitrolife AB Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Vitrolife AB. The current mfi is 63.28.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Vitrolife AB Daily Money Flow Index (MFI) ChartVitrolife AB Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Vitrolife AB.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-09-10ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-17MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-31CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-11-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-18STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-22ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-04MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-12-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-12-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-31STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-03WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-01-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-01-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-01-13STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-14MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-01-16STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-24CCI LONG ENTRY SHORT CLOSE100 crossover to upside

6.3. Candlestick Patterns

Vitrolife AB Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Vitrolife AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.704
Ma 20Greater thanMa 50211.905
Ma 50Greater thanMa 100215.733
Ma 100Greater thanMa 200229.025
OpenGreater thanClose222.900
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Vitrolife with someone you think should read this too:
  • Are you bullish or bearish on Vitrolife? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Vitrolife? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Vitrolife AB

I send you an email if I find something interesting about Vitrolife AB.


Comments

How you think about this?

Leave a comment

Stay informed about Vitrolife AB.

Receive notifications about Vitrolife AB in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.